Tech Company Financing Transactions
Cleveland Heartlab Funding Round
Glengary invested in a $4 million capital raise for Cleveland Heartlab. This venture round was announced by the company on 6/30/2011.
Transaction Overview
Company Name
Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$3,990,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6701 Carnegie Ave. 500
Cleveland, OH 44103
USA
Cleveland, OH 44103
USA
Phone
Website
Email Address
Overview
Specializing in next-generation cardiovascular disease prevention, diagnosis & management. We offer inflammation testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jake Orville
Chief Financial Officer
Pam Gornall
Chief Medical Officer
Marc Penn
VP - R & D
Cory Bystrom
VP - Sales
Steve Massaro
Browse more venture capital transactions:
Prev: 6/30/2011: Able Planet venture capital transaction
Next: 6/30/2011: Brightleaf venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs